Urinary tract infection in the users of depot-medroxyprogesterone acetate.
Berger
Richard E
RE
D000328:Adult; D016022:Case-Control Studies; D015331:Cohort Studies; D003076:Coitus Interruptus; D003271:Contraceptive Agents, Female / Q000008:administration & dosage / Q000009:adverse effects*; D003430:Cross-Sectional Studies; D003692:Delayed-Action Preparations; D005260:Female; D006801:Humans; D007492:Iran / Q000453:epidemiology; D008134:Long-Term Care; D017258:Medroxyprogesterone Acetate / Q000008:administration & dosage / Q000009:adverse effects*; D012008:Recurrence; D012306:Risk; D013223:Statistics as Topic; D014552:Urinary Tract Infections / Q000139:chemically induced* / Q000453:epidemiology
D003271:Contraceptive Agents, Female; D003692:Delayed-Action Preparations; D017258:Medroxyprogesterone Acetate